Publications by authors named "James Neiswender"

Claim this Profile
E
Epigenetic Derepression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression.
Varadha Balaji Venkadakrishnan, Adam Presser, Nathaniel C E Voss, James Neiswender, Lisa Brenan

Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13.
Jean Ching-Yi Tien, Jie Luo, Yu Chang, Yuping Zhang, Yunhui Cheng, James Neiswender

Cell Rep Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic Lethality.
Jean Ching-Yi Tien, Yu Chang, Yuping Zhang, Jonathan Chou, Yunhui Cheng, James Neiswender

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pigment cell progenitor heterogeneity and reiteration of developmental signaling underlie melanocyte regeneration in zebrafish.
William Tyler Frantz, Sharanya Iyengar, James Neiswender, Alyssa Cousineau, René Maehr

Elife· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIT Suppresses BRAF-Mutant Melanoma by Attenuating Oncogenic RAS/MAPK Signaling.
James V Neiswender, Robert L Kortum, Caitlin Bourque, Melissa Kasheta, Leonard I Zon

Cancer Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis.
Ziqiang Lin, James Neiswender, Bin Fang, Xuelei Ma, Jing Zhang

Oncotarget· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial AAV-IFN-β gene therapy eliminates invasive xenograft glioblastoma and improves survival in orthotopic syngeneic murine model.
Dwijit GuhaSarkar, James Neiswender, Qin Su, Guangping Gao, Miguel Sena-Esteves

Mol Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
Christine Guo Lian, Yufei Xu, Craig Ceol, Feizhen Wu, Allison Larson, James Neiswender

Cell· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis